mounjaro is a semaglutide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), major breakthrough for the treatment of obesity Switching from Wegovy to Mounjaro:

To be eligible for Wegovy, a person must have a body mass index (BMI) of: 30 or higher (obesity), or 27 or higher (overweight) with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol

There are also specific foods to avoid on semaglutide that tend to worsen GI symptoms at higher doses

In these cases, the factors driving a patients weight may not respond strongly to this type of treatment

Cognitive & Neuroprotection: Promoting memory, focus, and overall brain health

| What about a Mounjaro pill

amylovorus secretes bacterial extracellular vesicles (BEVs) enriched in oleic acid, a monounsaturated fatty acid that can be transferred to the mammary gland